Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...

Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The vaccine is recommended for use only in the run-up to RSV season. It's time for RSV, flu, and COVID shots, and the CDC has ...

Despite the Centers for Disease Control and Prevention's recommendations, vaccine rates against COVID-19, RSV, and the flu ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...